Jump to ContentJump to Main Navigation
Show Summary Details
In This Section

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982

Online
ISSN
1437-4331
See all formats and pricing
In This Section
Volume 44, Issue 1 (Jan 2006)

Issues

Erythrocyte membrane acetylcholinesterase activity in subjects with MTHFR 677C→T genotype

Stylianos Tsakiris
  • Department of Experimental Physiology, Medical School, University of Athens, Athens, Greece
/ Kleopatra H. Schulpis
  • Institute of Child Health, Research Centre, “Aghia Sophia” Children's Hospital, Athens, Greece
/ Evangelos D. Papaconstantinou
  • Institute of Child Health, Research Centre, “Aghia Sophia” Children's Hospital, Athens, Greece
/ Theodore Tsakiris
  • Department of Experimental Physiology, Medical School, University of Athens, Athens, Greece
/ Ioanna Tjamouranis
  • Institute of Child Health, Research Centre, “Aghia Sophia” Children's Hospital, Athens, Greece
/ Aglaia Giannoulia-Karantana
  • Institute of Child Health, Research Centre, “Aghia Sophia” Children's Hospital, Athens, Greece
Published Online: 2005-12-23 | DOI: https://doi.org/10.1515/CCLM.2006.005

Abstract

Background: Increased homocysteine (Hcy) blood levels are correlated with vascular and neurological problems.

Aim: The aim of the present study was to investigate erythrocyte membrane acetylcholinesterase (AChE) activity in subjects with the MTHFR C677T genotype in relation to Hcy.

Methods: Blood was obtained from 22 individuals with the MTHFR C677T genotype before and after folic acid supplementation and once from controls (n=30). Plasma folate, vitamin B12 and total antioxidant status (TAS) were measured with commercial kits, Hcy by a HPLC method and membrane enzyme activity spectrophotometrically.

Results: In MTHFR C677T carriers, AChE activity was significantly higher (4.20±0.12

× mg protein) and decreased to normal levels (3.14±0.10
× mg protein; p<0.001) after therapy. TAS differed slightly before and after treatment. Hcy levels were significantly higher before (22.4±2.8μM) compared to after (12.1±2.0μM; p<0.001) therapy and compared to controls (10.5±2.5μmol/L; p<0.001). In an in vitro study, incubation of Hcy-activated membrane AChE from controls with phenylalanine resulted in restoration of activity, but failed to reverse the stimulated enzyme from hyperhomocysteinaemic MTHFR C677T subjects before therapy. Alanine incubation protected the enzyme from Hcy activation in controls.

Conclusions: Increased membrane AChE activity may be due to high Hcy levels. In vitro, phenylalanine reversed the Hcy activation of the membrane enzyme from controls and alanine protected it from Hcy action.

Keywords: L-alanine; erythrocyte membrane acetylcholinesterase; hyperhomocysteinaemia; L-phenylalanine

References

  • 1.

    Lotti M. Cholinesterase inhibition: complexities in interpretation. Clin Chem 1995; 41:1814–8.

  • 2.

    Sussman JL, Harel M, Frolow F, Goldman A. Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine binding protein. Science 1991; 253:872–9.

  • 3.

    Mudd SH, Levy HL, Kran JP. Disorder in transsulfation. In: Scriver CR, Beadet AL, Sly WA, Valle D, editors. The metabolic and molecular bases of inherited diseases, 8th ed. New York: McGraw Hill, 2001:2007–56.

  • 4.

    Charlton CG, Crowell B Jr. Striatal dopamine, depletion, tremors, and hypokinesia following the intracranial injection of S-adenosylmethionine. A possible role of hypermethylation in Parkinsonism. Mol Chem Neuropathol 1995; 26:269–84. [Crossref]

  • 5.

    Kounitiotou-Krontiri P, Tsakiris S, Hadjigeorgiou G. Involvement of sulfhydryl groups in time dependent changes of diaphragm acetylcholinesterase activity by monovalent (Na+, Li+) cations. Biochem Mol Biol Int 1994; 33:485–96.

  • 6.

    Tsakiris S, Angelogianni P, Schulpis KH, Stavridis J. Protective effect of L-phenylalanine on rat brain acetylcholinesterase inhibition induced by free radicals. Clin Biochem 2000; 33:103–6.

  • 7.

    Tsakiris S, Schulpis KH. Alanine reverses the inhibitory effect of phenylalanine on acetylcholinesterase activity. Z Naturforsch 2002; 57c:506–11.

  • 8.

    Streck E, Zugno AI, Tagliari B, Sarkis J, Wajner M, Wannmacher C, et al. On the mechanism of the inhibition of Na+, K+ ATPase activity caused by homocysteine. Int J Dev Neurosci 2002; 20:77–81. [Crossref]

  • 9.

    Weisberg IS, Jacques PF, Selhub J, Bostom AG, Chen Z, Curtis Ellison R, et al. The 1298 A→C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis 2001; 156:409–15.

  • 10.

    Stefanello FM, Franzon R, Tagliari B, Wannmacher C, Wajner M, Wyse AT. Reduction of butyrylcholinesterase activity in rat serum subjected to homocysteinemia. Metab Brain Dis 2005; 20:97–103. [Crossref]

  • 11.

    Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 2001; 22:195–201. [Crossref]

  • 12.

    Papoutsakis C, Yiannakouris N, Manios Y, Papakonstantinou E, Magkos F, Schulpis KH, et al. Plasma homocysteine concentrations in a Mediterranean pediatric population are influenced by an interaction between the methylenetetrahydrofolate reductase 677 C→T genotype and folate status. J Nutr 2005; 135:383–8.

  • 13.

    Antoniadi T, Hadzis T, Kroupis C, Economou-Petersen E, Petersen MB. Prevalence of Factor V Leiden, Prothrombin G 20210 A, and MTHFR C677T mutations in a Greek population of blood donors. Am J Hematol 1999; 61:265–7.

  • 14.

    Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraki FM, Malinow MR. Vascular dysfunction in monkeys with diet induced hyperhomocysteinemia. J Clin Invest 1996; 98:24–9. [Crossref]

  • 15.

    Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. Hyperhomocysteinaemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 1997; 95:1119–21.

  • 16.

    McCully KS. Pathology of homocysteinuria, in: Homocysteine metabolism: From basic science to clinical medicine. Dordrecht: Kluwer, 1997:251–257.

  • 17.

    Olszewski AJ, McCully KS. Homocysteine metabolism and the oxidative modification of proteins and lipids. Free Radic Biol Med 1993; 14:763–93.

  • 18.

    Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high performance liquid chromatography with fluorescence detection. J Chromatogr 1987; 422:43–52.

  • 19.

    Saiki PK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-directed enzymatic application of DNA with a thermostable DNA polymerase. Science 1988; 239:487–91.

  • 20.

    Schulpis KH, Tsakiris S, Karikas GA, Moukas M, Behrakis P. Effect of diet on plasma total antioxidant status in phenylketonuric patients. Eur J Clin Nutr 2003; 57:383–7. [Crossref]

  • 21.

    Strube M, Haenen GR, Van den Berg H, Bast A. Pitfalls in a method for assessment of total antioxidant capacity. Free Radic Res 1997; 26:515–21.

  • 22.

    Galbraith DA, Watts DC. Changes in some cytoplasmic enzymes from red cells fractionated into age groups by centrifugation in Ficoll/Triosil gradients. Comparison of normal humans and patients with Duchenne muscular dystrophy. Biochem J 1980; 191:63–70.

  • 23.

    Kamber E, Poyiagi A, Deliconstantinos D. Modifications in the activities of membrane-bound enzymes during in vivo ageing of human and rabbit erythrocytes. Comp Biochem Physiol 1984; 77B:95–9.

  • 24.

    Lowry OH, Rosebrough NJ, Farr AL, Randal RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265–75.

  • 25.

    Ellman GI, Courtney D, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7:88–95. [Crossref]

  • 26.

    Bottiglieri T, Parnetti L, Arning E, Ortiz T, Amici S, Lenari A, et al. Plasma total homocysteine levels and the C677T mutation in the methylenetetrahydrofolate (MTHFR) gene: A study in an Italian population with dementia. Mech Ageing Dev 2001; 122:2013–23.

  • 27.

    Leblhuber F, Walli J, Widner B, Artner-Dworzak E, Fuchs O, Vrecko K. Homocysteine and B vitamins in dementia. Am J Clin Nutr 2001; 73:127–8.

  • 28.

    Cavalca V, Cighetti G, Bamonti F, Loaldi A, Bortone L, Novembrino C, et al. Oxidative stress and homocysteine in coronary artery disease. Clin Chem 2001; 47:887–92.

About the article

Corresponding author: Stylianos Tsakiris, PhD, Associate Professor, Department of Experimental Physiology, Medical School, University of Athens, P.O. Box 65257, 15401 Athens, Greece


Received: 2005-08-25

Accepted: 2005-10-18

Published Online: 2005-12-23

Published in Print: 2006-01-01



Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2006.005. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Maísa de Carvalho Corrêa, Paula Maldonado, Cíntia Saydelles da Rosa, Gilberto Lunkes, Daniele Sausen Lunkes, Rosilene Rodrigues Kaizer, Mushtaq Ahmed, Vera Maria Morsch, Maria Ester Pereira, and Maria Rosa Schetinger
Biomedicine & Pharmacotherapy, 2008, Volume 62, Number 5, Page 317

Comments (0)

Please log in or register to comment.
Log in